Purchases and Sales Made in Q4 2021 in Aeglea Bio Therapeutics, Inc. (AGLE)
This table provides information about the institutional ownership of Aeglea Bio Therapeutics, Inc. (AGLE) during Q4 2021. The information is specifically focused on institutions that hold shares of Aeglea BioTherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 11, 2022
Q4 2021
|
American International Group, Inc.
New York, NY |
SELL
|
- |
-644- 2.91% |
$2.25K - $5.42K
|
21.5K
$594K
|
|
|
Feb 15, 2022
Q4 2021
|
Penserra Capital Management LLC
Orinda, CA |
SELL
|
- |
-1.12KClosed |
$3.92K - $9.43K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.7K- 0.15% |
$5.95K - $14.3K
|
1.13M
$31.4M
|
|
|
Feb 14, 2022
Q4 2021
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-2.51K- 17.07% |
$8.8K - $21.2K
|
12.2K
$338K
|
|
|
Feb 11, 2022
Q4 2021
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-4.25K- 0.62% |
$14.9K - $35.8K
|
686K
$19M
|
|
|
Feb 14, 2022
Q4 2021
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-4.38K- 11.9% |
$15.3K - $36.9K
|
32.4K
$897K
|
|
|
Feb 14, 2022
Q4 2021
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-4.41K- 22.2% |
$15.4K - $37.1K
|
15.5K
$428K
|
|
|
Feb 16, 2022
Q4 2021
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-5.18K- 20.47% |
$18.1K - $43.6K
|
20.1K
$557K
|
|
|
Feb 09, 2022
Q4 2021
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-8.8KClosed |
$30.8K - $74.1K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
State Street Corp
Boston, MA |
SELL
|
- |
-8.9K- 1.16% |
$31.2K - $74.9K
|
758K
$21M
|
|
|
Feb 14, 2022
Q4 2021
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-10.8K- 6.02% |
$37.9K - $91.1K
|
169K
$4.67M
|
|
|
Feb 11, 2022
Q4 2021
|
Personal Cfo Solutions, LLC
|
SELL
|
- |
-10.9KClosed |
$38.1K - $91.7K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-11.2KClosed |
$39.2K - $94.2K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-11.2KClosed |
$39.3K - $94.7K
|
0
$0
|
|
|
Feb 15, 2022
Q4 2021
|
Metropolitan Life Insurance CO
New York, NY |
SELL
|
- |
-11.6KClosed |
$40.7K - $97.8K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
High Vista Strategies LLC
Boston, MA |
SELL
|
- |
-13.1KClosed |
$46K - $111K
|
0
$0
|
|
|
Feb 15, 2022
Q4 2021
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-15.4KClosed |
$53.7K - $129K
|
0
$0
|
|
|
Feb 08, 2022
Q4 2021
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-16K- 4.38% |
$56.1K - $135K
|
350K
$9.67M
|
|
|
Feb 07, 2022
Q4 2021
|
Sg Americas Securities, LLC
|
SELL
|
- |
-17.5K- 61.39% |
$61.4K - $148K
|
11K
$305K
|
|
|
Feb 10, 2022
Q4 2021
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-64.7K- 2.55% |
$226K - $545K
|
2.47M
$68.3M
|
|
|
Feb 25, 2022
Q4 2021
|
Alpha Centric Advisors LLC
San Juan, PR |
SELL
|
- |
-110KClosed |
$385K - $926K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-274K- 86.82% |
$960K - $2.31M
|
41.6K
$1.15M
|
|
|
Feb 14, 2022
Q4 2021
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-316K- 51.82% |
$1.11M - $2.66M
|
294K
$8.13M
|
|
|
Feb 14, 2022
Q4 2021
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-345K- 64.41% |
$1.21M - $2.9M
|
190K
$5.27M
|
|
|
Feb 14, 2022
Q4 2021
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-1.06M- 26.38% |
$3.71M - $8.92M
|
2.96M
$81.8M
|
|
|
Feb 14, 2022
Q4 2021
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-2.5M- 71.43% |
$8.75M - $21.1M
|
1M
$27.7M
|